Meng Qi Chen

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China.

NOD Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. It focuses on developing oral formulations for insulin, exenatide, interferon, human growth hormone, and more. The company was founded in 2005 and is headquartered in San Diego, CA.

Nexchem Pharmaceutical Co., Ltd. produces active pharmaceutical ingredients for global markets. Its products encompass azithromycin dihydrate, clarithromycin, roxithromycin, meropenem, fenofibrate, benserazide hydrochloride, and levosulpiride. The company was founded in December 2002 and is headquartered in Jinhua, China.

Yifang Technology Group Beijing Co, Ltd. (Yifang Ventures) is a venture capital firm located in China. The firm was founded in 2007 by Eric Xu. It is headquartered in Beijing, China.

CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China.

Shanghai Drug Farm Biological Technology Co., Ltd. is a Chinese private biotechnology company that focuses on developing innovative treatments for hepatitis B, heart and kidney diseases, and ROSAH syndrome. The company utilizes breakthrough technologies in genetics and AI to discover new treatments through its unique IDinVivo platform. This platform allows the direct assessment of gene targets in living animals with intact immune systems, which has led to the identification of novel innate immunity pathways and targets. Drug Farm is now advancing multiple first-in-class drug candidates into clinical development.

Part of Shanghai Bioveda Investment Management Consulting Co. Ltd., BVCF Investment Consulting (Shanghai) Ltd. is a healthcare investment company based in Shanghai, China. BVCF actively assists business owners and entrepreneurs to build their companies into world-class businesses. The Chinese company has raised five funds and invests in growth-stage healthcare companies from around the world, with a particular focus on innovative solutions that address unmet health needs. The company was founded by Zhi Yang and Ya Chao Zhao has been the CEO of the company since 2007.